CANCERTAIN LIMITED

Active United Kingdom

Research and experimental development on biotechnology

7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

CANCERTAIN LIMITED

Research and experimental development on biotechnology

Founded 25 Jan 2017 Active United Kingdom 7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

CLYZ LABS LIMITED 25 Jan 2017 — 31 Aug 2021
Accounts Submitted 28 Oct 2025 Next due 31 Mar 2026 3 months overdue
Confirmation Submitted 21 May 2026 Next due 12 Apr 2027 10 months remaining
Net assets £246K £181K 2023 year on year
Total assets £284K £158K 2023 year on year
Total Liabilities £37K £23K 2023 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Telephone

0800 000 0000

Website

www.example.com

Full company profile for CANCERTAIN LIMITED (10583623), an active life sciences and medical technology company based in United Kingdom. Incorporated 25 Jan 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2024
Type total-exemption-full
Next accounts 31 Mar 2025
Due by 31 Mar 2026 3 months overdue

Net Assets, Total Assets & Total Liabilities (2017–2023)

Cash in Bank

£33.64k

Decreased by £148.04k (-81%)

Net Assets

£246.41k

Decreased by £180.83k (-42%)

Total Liabilities

£37.10k

Increased by £22.84k (+160%)

Turnover

N/A

Employees

7

Debt Ratio

13%

Increased by 10 (+333%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Jan Year End
2023
31 Jan Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3
Grants 1

Investors (3)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2018Seed
Investor 2Aug 2018Seed
Investor 3Aug 2018Seed

Share Capital

Share Capital

Share allotments and capital structure

23 Allotments 1,418,993 Shares £747k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Apr 20262,100£1k£1k
7 Nov 2025492,174£4.922£4.922
7 Nov 2025149,376£75k£75k
3 Nov 2022150,000£150k£1
3 Nov 202284,023£84k£1

Officers

Officers

2 active 1 resigned
Status
Kataria, Zalakben HimanshuDirectorIndianUnited Kingdom4025 Jan 2017Active
Whitcombe, David MarkDirectorBritishEngland631 Feb 2021Active

Shareholders

Shareholders (44)

The Gm & Cheshire Life Sciences Fund Lp
23.4%
1,112,538
Himanshu Kataria
21.0%
1,000,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Himanshu Laxmidas Kataria

British

Active
Notified 25 Jan 2017
Residence England
DOB June 1979
Nature of Control
  • Significant Influence Or Control

Zalakben Himanshu Kataria

Indian

Active
Notified 25 Jan 2017
Residence United Kingdom
DOB February 1986
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 May 2026GazetteGazette Filings Brought Up To Date
26 May 2026GazetteGazette Notice Compulsory
21 May 2026Confirmation StatementConfirmation statement made on 29 Mar 2026 with updates
21 Apr 2026CapitalAllotment of shares (GBP 75,784.41335) on 20 Apr 2026
12 Nov 2025CapitalAllotment of shares (GBP 46.91335) on 7 Nov 2025
27 May 2026 Gazette

Gazette Filings Brought Up To Date

26 May 2026 Gazette

Gazette Notice Compulsory

21 May 2026 Confirmation Statement

Confirmation statement made on 29 Mar 2026 with updates

21 Apr 2026 Capital

Allotment of shares (GBP 75,784.41335) on 20 Apr 2026

12 Nov 2025 Capital

Allotment of shares (GBP 46.91335) on 7 Nov 2025

Recent Activity

Latest Activity

Gazette Filings Brought Up To Date

1 weeks ago on 27 May 2026

Gazette Notice Compulsory

1 weeks ago on 26 May 2026

Confirmation statement made on 29 Mar 2026 with updates

2 weeks ago on 21 May 2026

Allotment of shares (GBP 75,784.41335) on 20 Apr 2026

1 months ago on 21 Apr 2026

Allotment of shares (GBP 46.91335) on 7 Nov 2025

6 months ago on 12 Nov 2025